Skip to Content

EchoGen

Active Substance: dodecafluoropentane
Common Name: dodecafluoropentane
ATC Code: V08DA
Marketing Authorisation Holder: Sonus Pharmaceuticals Ltd.
Active Substance: dodecafluoropentane
Status: Withdrawn
Authorisation Date: 1998-07-17
Therapeutic Area: Echocardiography
Pharmacotherapeutic Group: Contrast media

Therapeutic Indication

EchoGen is a transpulmonary echocardiographic contrast agent for use in patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers, enhance left ventricular border delineation with resulting improvement in wall motion visualisation.

EchoGen should only be used in patients where the study without contrast enhancement is inconclusive.

The marketing authorisation for EchoGen has been withdrawn at the request of the marketing authorisation holder.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide